Anionic liposomes, which have a negatively charged surface, are being investigated extensively for drug delivery applications
Market Players: The rise of new models like virtual-first care and organizations like Hims/Hers offering access to weight management programsincluding compounded or prescription GLP-1sfurther drives awareness and accessibility, increasing demand for employer coverage
GLP-1 analogues, including Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, present diverse choices for individuals seeking effective weight management solutions
Originally developed to treat type 2 diabetes, GLP-1 medications have gained widespread attention for their powerful effects on weight loss and metabolic health
Hollins DL, Suliman HB, Piantadosi CA, Carraway MS